Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket

Published 19/09/2022, 11:53
Updated 19/09/2022, 12:40
© Reuters.  Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket

Gainers

  • FOXO Technologies Inc. (NYSE: FOXO) rose 161% to $10.50 in pre-market trading after dipping 52% on Friday.
  • Amprius Technologies, Inc. (NYSE: AMPX) shares rose 20.5% to $10.00 in pre-market trading after declining 17% on Friday.
  • bluebird bio, Inc. (NASDAQ: BLUE) rose 18.5% to $7.52 in pre-market trading. bluebird bio disclosed that the Food and Drug Administration approved its gene therapy for a rare neurodegenerative disease.
  • NexImmune, Inc. (NASDAQ: NEXI) rose 15.6% to $0.76 in pre-market trading. NexImmune and Selexis recently signed a service agreement to develop cell lines targeting rare cancers and autoimmune diseases.
  • Secoo Holding Limited (NASDAQ: SECO) rose 14% to $0.3999 in pre-market trading. Aladdin Technology Group recently agreed to invest RMB1.3 million in the company.
  • VEON Ltd. (NASDAQ: VEON) rose 13.8% to $0.41 in pre-market trading after dropping 18% on Friday. VEON Group’s consolidated revenue rose 3.1% year-on-year for the first eight months of 2022.
  • Senti Biosciences, Inc. (NASDAQ: SNTI) rose 13.7% to $1.82 in pre-market trading after dipping around 29% on Friday.
  • Golden Minerals Company (NYSE: AUMN) rose 11.4% to $0.2562 in pre-market trading after dropping 10% on Friday.
  • Kalera Public Limited Company (NASDAQ: KAL) rose 11.1% to $1.50 in pre-market trading after declining 27% on Friday. Kalera posted Q2 adjusted loss of $1.20 per share.
  • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) rose 10.2% to $9.91 in pre-market trading after dropping 46% on Friday.
  • NEXGEL, Inc. (NASDAQ: NXGL) rose 9.2% to $1.78 in pre-market trading. NexGel, last month, posted a Q2 loss of $0.19 per share.
  • Cepton, Inc. (NASDAQ: CPTN) rose 8.5% to $1.78 in pre-market trading. Cepton, last month, posted a Q2 loss of $0.09 per share.
  • Akerna Corp. (NASDAQ: KERN) rose 8% to $0.1403 in pre-market trading after tumbing more than 6% on Friday.
  • Rent the Runway, Inc. (NASDAQ: RENT) shares rose 6.9% to $3.10 in pre-market trading. The company recently reported issued Q3 guidance below estimates and announced a workforce reduction of 24% of corporate employees..
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Don’t forget to check out our premarket coverage here .

Losers

  • Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell 29.3% to $0.41 in pre-market trading after jumping 53% on Friday. Panbela Therapeutics recently filed for public offering of 28.9 million shares of common stock and common stock purchase warrants.
  • Lannett Company, Inc. (NYSE: LCI) fell 21.7% to $0.45 in pre-market trading after surging 25% on Friday. Lannett Company recently reported Q4 FY22 sales of $74.2 million, down from $106 million a year ago.
  • iBio, Inc. (NYSE: IBIO) fell 21.5% to $0.3610 in pre-market trading after jumping around 50% on Friday.
  • SoundHound AI, Inc. (NASDAQ: SOUN) fell 16.6% to $3.12 in pre-market trading following a 15% surge on Friday.
  • Innate Pharma S.A. (NASDAQ: IPHA) shares fell 14.3% to $2.63 in pre-market trading. Innate Pharma recently reported H1 sales of €45.6 million up from €14.67 million year over year.
  • Nexalin Technology, Inc. (NASDAQ: NXL) shares fell 10.7% to $2.01 in pre-market trading after tumbling 45% on Friday. Nexalin Technology priced its IPO at $4.15 per share.
  • Spero Therapeutics, Inc. (NASDAQ: SPRO) shares fell 10% to $0.81 in pre-market trading. Spero Therapeutics recently said it received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr.
  • Valneva SE (NASDAQ: VALN) fell 9.8% to $14.55 in pre-market trading. Valneva and IDT Biologika agreed on termination of their COVID-19 collaboration.
  • Hempacco Co., Inc. (NASDAQ: HPCO) fell 8.5% to $2.60 in pre-market trading amid post-IPO volatility.
  • Marathon Digital Holdings, Inc. (NASDAQ: MARA) fell 8.4% to $10.00 in pre-market trading after declining around 10% on Friday. DA Davidson recently maintained Marathon Digital Holdings with a Buy and lowered the price target from $30 to $22.
  • Caribou Biosciences, Inc. (NASDAQ: CRBU) fell 7.7% to $10.50 in pre-market trading after declining 11% on Friday.
  • Venator Materials PLC (NYSE: VNTR) fell 7.5% to $1.35 in pre-market trading.
  • Borr Drilling Limited (NYSE: BORR) fell 7.4% to $3.62 in pre-market trading after dropping more than 7% on Friday.
  • Intellinetics, Inc. (NYSE: INLX) fell 7.3% to $4.88 in pre-market trading after gaining around 10% on Friday.
  • TORM plc (NASDAQ: TRMD) shares fell 6.4% to $20.28 in pre-market trading.
  • Take-Two (NASDAQ:TTWO) Interactive Software, Inc. (NASDAQ: TTWO) fell 5.8% to $117.01 in pre-market trading. Take-Two's Grand Theft Auto VI gameplay was leaked online, Bloomberg News reported.
  • Coinbase (NASDAQ:COIN) Global, Inc. (NASDAQ: COIN) fell 4.8% to $70.37 in pre-market trading after dropping over 4% on Friday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.